Journal ArticleOPEN ACCESS

Cis‐platinum vestibular toxicity

Cancer (1981) 47(5) 857-859
DOI: 10.1002/1097-0142(19810301)47:5<857::AID-CNCR2820470508>3.0.CO;2-M
67Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cis‐diamminedichloroplatinum has been proven to be an effective neoplastic agent. Nephrotoxicity and ototoxicity are two prominent side effects of this drug. Investigation of ototoxicity has been limited to auditory function. This report details the first known case of vestibular toxicity following platinum therapy. In addition, a prospective vestibular testing program is reported. Cancer 47:857–8589, 1981. Copyright © 1981 American Cancer Society

Cite

CITATION STYLE

APA

Schaefer, S. D., Wright, C. G., Post, J. D., & Frenkel, E. P. (1981). Cis‐platinum vestibular toxicity. Cancer, 47(5), 857–859. https://doi.org/10.1002/1097-0142(19810301)47:5<857::AID-CNCR2820470508>3.0.CO;2-M

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free